References
1 Klein I, Danzi S. Thyroid disease and the heart.
Curr Probl Cardiol. 2016. February; 41 2: 65– 92.
2 Biondi B. Mechanisms in endocrinology: Heart failure
and thyroid dysfunction. Eur J Endocrinol. 2012. November; 167 5: 609–
18
3 Dahl P, Danzi S, Klein I. Thyrotoxic cardiac
disease. Curr Heart Fail Rep. 2008;5:170–176.
4 Nayak B, Burman K. Thyrotoxicosis and thyroid
storm. Endocrinol Metab Clin North Am. 2006;35:663–686.
5 Greyson CR. Pathophysiology of right ventricular
failure. Crit Care Med. 2008; 36(1 Suppl):S57–S65
6 Stretch R, Sauer CM, Yuh DD, Bonde P. National
trends in the utilization of short‐term mechanical circulatory support:
incidence, outcomes, and cost analysis. J Am Coll Cardiol. 2014;
64:1407–1415.
7 Imamura T, Kinugawa K, Kinoshita O, Nawata K, Ono M:
High pulmonary vascular resistance in addition to low right ventricular
stroke work index effectively predicts biventricular assist device
requirement. J Artif Organs 2016; 19(1): 44–53.
8 Drazner M.H., Velez-Martinez M., Ayers C.R., et al.
Relationship of right- to left-sided ventricular filling pressures in
advanced heart failure: insights from the ESCAPE trial. Circ Heart Fail.
2013; 6:264–270.
9 Kuchibhotla S, Esposito ML, Breton C, et al. Acute
biventricular mechanical circulatory support for cardiogenic shock. J Am
Heart Assoc. 2017;6:e006670.
10 Anderson MB, Goldstein J, Milano C, et al. Benefits
of a novel percutaneous ventricular assist device for right heart
failure: the prospective RECOVER RIGHT study of the Impella RP device. J
Heart Lung Transplant. 2015; 34:1549–1560.